INHIBITION OF MALIGNANT MESOTHELIOMA CELL MATRIX METALLOPROTEINASE PRODUCTION AND INVASION BY A NOVEL NUTRIENT MIXTURE

Author： Roomi M. Waheed Ivanov Vadim Kalinovsky Tatiana Niedzwiecki Aleksandra Rath Matthias

ISSN： 1521-0499

Source： Experimental Lung Research, Vol.32, Iss.3-4, 2006-07, pp. : 69-79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Malignant mesothelioma (MM), an asbestos-associated cancer with no known cure, is a highly aggressive tumor causing profound morbidity and nearly universal mortality. Extracellular matrix (ECM) matrix metalloproteinases (MMPs) produced by tumor and stromal cells play a key role in tumor invasion and metastasis. Prevention of ECM degradation by MMP inhibition has been shown to be a promising therapeutic approach to inhibition of cancer development. Based on reported anticancer properties, the authors investigated the effect of a mixture (NM) containing lysine, proline, ascorbic acid, and green tea extract on MM cell line MSTO-211 H proliferation (by [MTT] [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] assay), MMP secretion (by gelatinase zymography), invasion (through Matrigel), and morphology (by hematoxylin and eosin [H&E] staining). MMP-2 and phorbol 12-myristate 13-acetate (PMA)-induced MMP-9 secretion were inhibited by NM in a dose-dependent fashion, with virtual total inhibition at 500 μg/ml NM. Invasion through Matrigel was inhibited at 50, 100, and 500 μg/ml by 27%, 36%, and 100%, respectively. NM was not toxic to the MM cell line, and H&E staining did not indicate any changes at and below 100 μg/ml concentration. In conclusion, NM significantly inhibited MM cell MMP secretion and invasion—both important parameters for cancer prevention, suggesting NM is an effective treatment strategy for MM.